Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (“PEMBROREAL” Study)
Article in Cancers (May 2024)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Article in Cancers (May 2024)
Article in Cancer Research (April 2024)
Article in British Journal of Cancer (February 2024)